2016 CIOPORA Guide to Plant Breeders' Rights
CIOPORA annual magazine on Intellectual Property protection for plant innovations. Produced in cooperation with FloraCulture International. Read in the 2016 issue: - CIOPORA completes positions on Plant Breeders´ Rights - Does the U.S. miss out on additional new varieties developed abroad? - Update on the Nagoya Protocol and its EU implementation - Intellectual Property Systems: a tool, not a goal - European Trademarks and Variety : The chaos has arrived.
CIOPORA annual magazine on Intellectual Property protection for plant innovations. Produced in cooperation with FloraCulture International.
Read in the 2016 issue:
- CIOPORA completes positions on Plant Breeders´ Rights
- Does the U.S. miss out on additional new varieties developed abroad?
- Update on the Nagoya Protocol and its EU implementation
- Intellectual Property Systems: a tool, not a goal
- European Trademarks and Variety : The chaos has arrived.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Guide</strong> To <strong>Plant</strong> <strong>Breeders'</strong> <strong>Rights</strong><br />
<strong>2016</strong><br />
The one-year window<br />
The America Invents Act, effective<br />
March 16, 2013, among<br />
other things, restates the ‘novelty’<br />
requirement for all U.S. Patents,<br />
including traditional <strong>Plant</strong> Patents.<br />
Under this standard, ‘novelty’ is<br />
now deemed <strong>to</strong> end in the United<br />
States when a plant was “on sale,<br />
or otherwise available <strong>to</strong> the public<br />
before the effective filing date”<br />
anywhere in the world. However, if<br />
the public availability was less than<br />
one year prior <strong>to</strong> the filing date of<br />
the <strong>Plant</strong> Patent Application, then<br />
it will not destroy novelty so long as<br />
the public availability was the result<br />
of actions of the breeder/inven<strong>to</strong>r<br />
(or another who obtained the<br />
plant directly or indirectly from the<br />
breeder/inven<strong>to</strong>r).<br />
Thus, though the novelty standards<br />
are similar for U.S. <strong>Plant</strong> Patents<br />
and UPOV <strong>Plant</strong> Breeder’s <strong>Rights</strong><br />
with regard <strong>to</strong> availability of the<br />
new variety within the terri<strong>to</strong>ry in<br />
which protection is being sought,<br />
they differ greatly with regard <strong>to</strong><br />
public availability outside of the<br />
terri<strong>to</strong>ry.<br />
More specifically, unlike the<br />
UPOV ‘novelty’ standard of 4 years<br />
(6 years for trees and vines) for<br />
availability outside the terri<strong>to</strong>ry, a<br />
patentability issue will likely arise<br />
for a U.S. <strong>Plant</strong> Patent if there was<br />
plant availability (sufficient for the<br />
general public <strong>to</strong> gain possession of<br />
the plant) anywhere in the world<br />
more than one year prior <strong>to</strong> the<br />
effective filing date in the United<br />
States. <strong>Plant</strong> origina<strong>to</strong>rs/inven<strong>to</strong>rs<br />
outside the U.S. need <strong>to</strong> be alert <strong>to</strong><br />
this important precondition – <strong>Plant</strong><br />
Patent protection must be timely<br />
sought in the United States once a<br />
new plant is introduced anywhere<br />
in the world.<br />
Global harmonization?<br />
Thus, one is left <strong>to</strong> reflect on whether<br />
this issue may be resulting in the<br />
United States missing out on the introduction of<br />
additional asexually reproduced plant varieties<br />
from abroad due <strong>to</strong> the owners of those new varieties<br />
being discouraged from entering the U.S. as a<br />
result of the atypically stringent ‘novelty’ standard<br />
applied <strong>to</strong> U.S. <strong>Plant</strong> Patents. For example, if an<br />
origina<strong>to</strong>r of a new plant variety introduced the<br />
new variety abroad >1 year earlier, why would he/<br />
she then bring that variety in<strong>to</strong> the U.S. when no<br />
<strong>Plant</strong> Patent protection can now be obtained?<br />
This raises the ultimate question: Should the<br />
traditional <strong>Plant</strong> Patent law of the United States<br />
(35 U.S.C. § 161 et seq.) should be modified <strong>to</strong><br />
achieve global harmonization with respect <strong>to</strong> the<br />
definitions of plant ‘novelty’? Doing so would<br />
likely make the current ‘novelty’ standard being<br />
applied more realistic in view of the unique<br />
challenges faced by persons developing new<br />
plant varieties while simultaneously providing<br />
the U.S. with the benefit of an expanded array<br />
of recently-created plants. Thus, it seems there<br />
is a strong argument that an adjustment <strong>to</strong> the<br />
novelty standard for U.S. <strong>Plant</strong> Patents would be<br />
beneficial for both plant breeders and the public<br />
as a whole. |||